Inflammatory infiltration of metaplastic epithelium and correlation to previous diagnosis of esophagitis and Barrett's length

References

• Zhang HY, Zhang Q, Zhang X, Yu C, Huo X, Cheng E, Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells. Am J Physiol Gastrointest Liver Physiol 2011;300:454–60.
   PubMed Web of Science ®Google Scholar
• Tack J, Fass R. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder? Aliment Pharmacol Ther 2004;19(Suppl 1):28–34.
   PubMedGoogle Scholar
• Souza RF, Huo X, Mittal V, Schuler CM, Carmack SW, Zhang HY, Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 2009;137:1776–84.
   PubMed Web of Science ®Google Scholar
• Moons LM, Kusters JG, van Delft JH, Kuipers EJ, Gottschalk R, Geldof H, A pro-inflammatory genotype predisposes to Barrett's esophagus. Carcinogenesis 2008;29:926–31.
   PubMedGoogle Scholar
• Zentilin P, Reglioni S, Savarino V. Pathophysiological characteristics of long- and short-segment Barrett's oesophagus. Scand J Gastroenterol Suppl 2003;239:40–3.
   Google Scholar
• Loughney T, Maydonovitch CL, Wong RK. Esophageal manometry and ambulatory 24-h pH monitoring in patients with short and long segment Barrett's esophagus. Am J Gastroenterol 1998;93:916–19.
   PubMed Web of Science ®Google Scholar
• Wakelin DE, Al-Mutawa T, Wendel C, Green C, Garewal HS, Fass R. A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc 2003;58:350–5.
   PubMed Web of Science ®Google Scholar
• Fass R, Hell RW, Garewal HS, Martinez P, Pulliam G, Wendel C, Correlation of oesophageal acid exposure with Barrett's oesophagus length. Gut 2001;48:310–13.
   PubMed Web of Science ®Google Scholar
• Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus. Dig Dis Sci 2002;472:256–64.
   Google Scholar
• Guelrud M, Ehrlich EE. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 2001;53:559–65.
   PubMed Web of Science ®Google Scholar
• Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172–80.
   PubMed Web of Science ®Google Scholar
• Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, Saeed IT, Burnham WR, Farthing MJ. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 2002;50:451–9.
   PubMed Web of Science ®Google Scholar
• Fitzgerald RC, Abdalla S, Onwuegbusi BA, Sirieix P, Saeed IT, Burnham WR, Inflammatory gradient in Barrett's oesophagus: implications for disease complications. Gut 2002;51:316–22.
   PubMedGoogle Scholar
• Wong NA, Wilding J, Bartlett S, Liu Y, Warren BF, Piris J, CDX1 is an important molecular mediator of Barrett's metaplasia. Proc Natl Acad Sci USA 2005;102:7565–70.
   PubMed Web of Science ®Google Scholar
• Kazumori H, Ishihara S, Kinoshita Y. Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development. Gut 2009;58:620–8.
   PubMedGoogle Scholar
• Stupack DG, Cheresh DA. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 2002;115:3729–38.
   PubMed Web of Science ®Google Scholar
• Souza RF, Shewmake K, Terada LS. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 2002;122:299–307.
   PubMed Web of Science ®Google Scholar
• Morgan C, Alazawi W, Sirieix P, Freeman T, Coleman N, Fitzgerald R. In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett's adenocarcinoma cell line. Am J Gastroenterol 2004;99:218–24.
   PubMedGoogle Scholar
• Colleypriest BJ, Ward SG, Tosh D. How does inflammation cause Barrett's metaplasia? Curr Opin Pharmacol 2009;96:721–6.
   Google Scholar
• O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol 2005;100:1257–64.
   PubMed Web of Science ®Google Scholar
• Wani S, Sampliner RE, Weston AP, Mathur S, Hall M, Higbee A, Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus. Aliment Pharmacol Ther 2005;22:627–33.
   PubMedGoogle Scholar
• Frazzoni M, Savarino E, Manno M, Melotti G, Mirante VG, Mussetto A, Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther 2009;30:508–15.
   PubMedGoogle Scholar
• Tack J, Blondeau K. Weakly acidic reflux. Dig Dis 2009;27:58–61.
   PubMedGoogle Scholar
• Oberg S, Ritter MP, Crookes PF, Fein M, Mason RJ, Gadensytätter M, Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett's esophagus and duodenogastroesophageal reflux. J Gastrointest Surg 1998;2:547–753; discussion 553-4.
   PubMedGoogle Scholar
• Pandeya N, Webb PM, Sadeghi S, Green AC, Whiteman DC; Australian Cancer Study. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants? Gut 2010;59:31–8.
   PubMedGoogle Scholar
• Nguyen DM, Richardson P, El-Serag HB. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology 2010;138:2260–6.
   PubMed Web of Science ®Google Scholar
• Emerenziani S, Habib FI, Ribolsi M, Caviglia R, Guarino MP, Petitti T, Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther 2006;23:751–7.
   PubMedGoogle Scholar
• Cameron AJ. Barrett's esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol 1999;94:2054–9.
   PubMed Web of Science ®Google Scholar
• Patti MG, Goldberg HI, Arcerito M, Bortolasi L, Tong J, Way LW. Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury. Am J Surg 1996;171:182–6.
   PubMed Web of Science ®Google Scholar
• Kasapidis P, Vassilakis JS, Tzovaras G, Chrysos E, Xynos E. Effect of hiatal hernia on esophageal manometry and pH-metry in gastroesophageal reflux disease. Dig Dis Sci 1995;40:2724–30.
   PubMedGoogle Scholar
• Savarino E, Zentilin P, Frazzoni M, Cuoco DL, Pohl D, Dulbecco P, Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers. Neurogastroenterol Motil 2010;22:1061–e280.
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Aguirre T, Kuebeler M, Sampliner RE. The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy. Aliment Pharmacol Ther 2004;19:1255–60.
   PubMedGoogle Scholar
• Dickman R, Green C, Chey WD, Jones MP, Eisen GM, Ramirez F, Clinical predictors of Barrett's esophagus length. Gastrointest Endosc 2005;62:675–81.
   PubMedGoogle Scholar